Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GRANULES INDIA   ACTAVIS
EQUITY SHARE DATA
    GRANULES INDIA
Mar-23
ACTAVIS
Dec-18
GRANULES INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38116,126-   
Low Rs22710,818-   
Sales per share (Unadj.) Rs186.43,955.8-  
Earnings per share (Unadj.) Rs21.3-1,274.2-  
Cash flow per share (Unadj.) Rs29.0416.9-  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs116.416,315.7-  
Shares outstanding (eoy) m242.04332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.63.4 47.9%   
Avg P/E ratio x14.2-10.6 -134.8%  
P/CF ratio (eoy) x10.532.3 32.5%  
Price / Book Value ratio x2.60.8 316.5%  
Dividend payout %7.00-   
Avg Mkt Cap Rs m73,6114,480,758 1.6%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m4,2030-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m45,1191,315,689 3.4%  
Other income Rs m14325,160 0.6%   
Total revenues Rs m45,2621,340,849 3.4%   
Gross profit Rs m9,13334,478 26.5%  
Depreciation Rs m1,845562,428 0.3%   
Interest Rs m55975,923 0.7%   
Profit before tax Rs m6,872-578,713 -1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m1,706-7,334 -23.3%   
Profit after tax Rs m5,166-423,784 -1.2%  
Gross profit margin %20.22.6 772.5%  
Effective tax rate %24.81.3 1,958.7%   
Net profit margin %11.4-32.2 -35.5%  
BALANCE SHEET DATA
Current assets Rs m25,741539,627 4.8%   
Current liabilities Rs m18,135477,372 3.8%   
Net working cap to sales %16.94.7 356.3%  
Current ratio x1.41.1 125.6%  
Inventory Days Days1420 73.8%  
Debtors Days Days7766 115.7%  
Net fixed assets Rs m23,290148,929 15.6%   
Share capital Rs m2420-   
"Free" reserves Rs m27,9270-   
Net worth Rs m28,1695,426,601 0.5%   
Long term debt Rs m1,4861,910,903 0.1%   
Total assets Rs m49,0318,483,012 0.6%  
Interest coverage x13.3-6.6 -200.6%   
Debt to equity ratio x0.10.4 15.0%  
Sales to assets ratio x0.90.2 593.3%   
Return on assets %11.7-4.1 -284.8%  
Return on equity %18.3-7.8 -234.8%  
Return on capital %25.1-4.8 -517.6%  
Exports to sales %81.00-   
Imports to sales %31.30-   
Net fx Rs m22,4060-   
CASH FLOW
From Operations Rs m7,387470,046 1.6%  
From Investments Rs m-1,914258,229 -0.7%  
From Financial Activity Rs m-4,403-806,740 0.5%  
Net Cashflow Rs m1,068-78,073 -1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare GRANULES INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GRANULES INDIA With: IND. SWIFT  CONCORD DRUGS  AMI ORGANICS  GANGA PHARMACEUTICALS  MANGALAM DRUGS  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.